A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection

June 5, 2023 updated by: Marysia Tweet, Mayo Clinic

Role of the Neurovascular System in Spontaneous Coronary Artery Dissection (SCAD)

The purpose of this research is to compare sympathetic function (flight or fight system) and arterial health including structure and mechanics of participants with history of spontaneous coronary artery dissection (SCAD) to age and sex matched control participants.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Recruiting
        • Mayo Clinic Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • For SCAD patients: history of SCAD as confirmed by coronary angiography or cardiac computed tomography angiography
  • For controls: no cardiac disease history

Exclusion Criteria:

  • Pregnancy
  • Known or suspected unstable cardiac condition within 4 weeks of the study
  • Active treatment with anticoagulation or dual antiplatelet therapy
  • Prisoner

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Spontaneous coronary artery dissection (SCAD) group
Subject with a history of SCAD will undergo a series of diagnostic studies to assess neurovascular function.
We will measure arterial stiffness using arterial tonometry.
We will collect limited ultrasound images of the heart.
We will perform ultrasound imaging of the carotid artery.
We will measure the elastic properties of the arteries using elastography.
We will measure the ankle-brachial index to assess peripheral artery blood flow.
We will measure sympathetic nerve activity at rest and in response to isometric handgrip, mental stress test, cold pressor test, Valsalva maneuvers.
Other: Healthy Control Group
Healthy subjects will undergo a series of diagnostic studies to assess neurovascular function.
We will measure arterial stiffness using arterial tonometry.
We will collect limited ultrasound images of the heart.
We will perform ultrasound imaging of the carotid artery.
We will measure the elastic properties of the arteries using elastography.
We will measure the ankle-brachial index to assess peripheral artery blood flow.
We will measure sympathetic nerve activity at rest and in response to isometric handgrip, mental stress test, cold pressor test, Valsalva maneuvers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arterial thickness
Time Frame: Baseline
Measured by carotid ultrasound intimal media thickness reporting in mm
Baseline
Arterial stiffness
Time Frame: Baseline
Measured by carotid ultrasound pulse wave velocity reporting in m/s
Baseline
Baroreflex sensitivity
Time Frame: Baseline
The slope between heart rate and blood pressure at rest and during the Valsalva Maneuver (ms/mmHg)
Baseline
Sympathetic response to stress
Time Frame: Baseline
Blood pressure or muscle sympathetic nerve activity response to sympathoexcitatory stressors (mm/Hg or bursts/min).
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Marysia Tweet, MD, MS, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

January 16, 2023

First Submitted That Met QC Criteria

January 16, 2023

First Posted (Actual)

January 26, 2023

Study Record Updates

Last Update Posted (Actual)

June 6, 2023

Last Update Submitted That Met QC Criteria

June 5, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Arterial Tonometry

3
Subscribe